Search
Menu
Home
HTB
2000
April
01
1 April 2000
Contents
Other news
French National Drug Agency re-commends use of IL-2 if HAART does not lead to an increase in CD4 count to greater than 200 cells/mm3
Public Health Service (US) releases updated guidelines for treatment of HIV positive pregnant women (April 2000)
French Health Authority approves enteric coated ddI
U.S. FDA approves film-coated nelfinavir mesylate (Viraceptâ„¢)
St John’s Wort
PDFs
Volume 1 Number 1 April 2000 PDF
HTB RSS
Early access
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
HIV organisations support trans and non-binary communities against the unworkable EHRC guidelines
30 June 2025
Long-acting injectable PrEP approved in the US: priced at $28,000 a year
28 June 2025
Clinical studies of two once-weekly pipeline compounds put on hold
27 June 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate